JNCE

Jounce Therapeutics, Inc. Common Stock

Delisted

JNCE was delisted on the 3rd of May, 2023.

83 hedge funds and large institutions have $210M invested in Jounce Therapeutics, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 28 increasing their positions, 22 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
83
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.1M
Puts
$1.15M
Net Calls
Net Calls Change

Top Buyers

1 +$3.32M
2 +$1.94M
3 +$1.85M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$1.57M
5
Two Sigma Investments
Two Sigma Investments
New York
+$1.56M

Top Sellers

1 -$43M
2 -$11.7M
3 -$11M
4
Ameriprise
Ameriprise
Minnesota
-$3.97M
5
FI
Fosun International
China
-$3.58M
Name Holding Trade Value Shares
Change
Change in
Stake
101
102
103
104
105
106
107
108
109
110
111
112
113
114